Scinai Immunotherapeutics's market cap is currently $2.76M. The company's EPS TTM is $0.305; its P/E ratio is 10.94; Scinai Immunotherapeutics is scheduled to report earnings on May 29, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Operating Income	$ -9.71M	$ -11.06M	$ -10.87M	$ 2.28M	$ -22.69M
EBITDA	$ -9.19M	$ -10.50M	$ -10.39M	$ 2.75M	$ -22.21M
Net Income	$ -6.50M	$ -5.80M	$ -8.21M	$ -1.39M	$ -31.62M
Balance Sheet
Cash & Short-Term Investments	$ 4.87M	$ 14.07M	$ 17.37M	$ 2.93M	$ 20.98M
Total Assets	$ 17.47M	$ 27.07M	$ 32.04M	$ 17.71M	$ 33.52M
Total Debt	$ 20.56M	$ 21.54M	$ 28.98M	$ 20.90M	$ 38.02M
Net Debt	$ 15.69M	$ 7.47M	$ 11.61M	$ 17.97M	$ 17.03M
Total Liabilities	$ 22.04M	$ 28.83M	$ 31.05M	$ 22.25M	$ 52.36M
Stockholders' Equity	$ -4.57M	$ -1.76M	$ 982.00K	$ -4.54M	$ -18.84M
Cash Flow
Free Cash Flow	$ -10.02M	$ -8.10M	$ -7.57M	$ -24.48M	$ -24.47M
Operating Cash Flow	$ -9.38M	$ -7.26M	$ -7.43M	$ -22.57M	$ -22.31M
Investing Cash Flow	$ -637.00K	$ -836.00K	$ -139.00K	$ -1.85M	$ -2.08M
Financing Cash Flow	$ 1.09M	$ 6.78M	$ 21.43M	$ 4.27M	$ 24.68M

Currency in USD

Scinai Immunotherapeutics Earnings and Revenue History

Income Statement >

Scinai Immunotherapeutics Debt to Assets

Balance Sheet >

Scinai Immunotherapeutics Cash Flow

Cash Flow >

Scinai Immunotherapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing